Sandu Pharmaceuticals Ltd.
Snapshot View

55.50 +0.30 ▲0.5%

30 July 2021, 09:52:00 A.M.
Volume: 2

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sandu.in
Financial Indicators
Market Cap 39.09 Cr.
Earnings per share (EPS) 1.54 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 35.76 Trailing Twelve Months Ending 2021-03
Industry PE 34.39 Trailing Twelve Months Ending 2021-03
Book Value / Share 33.04 Trailing Twelve Months Ending 2021-03
Price to Book Value 1.67 Calculated using Price: 55.20
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 0.71 Cr. 7,081,000 Shares
FaceValue 10
Company Profile

Sandu Pharmaceuticals incorporated in 1985, is engaged in manufacturing of ayurvedic medicines. The company operates a distribution network in India as well as in the overseas markets.

The company is part of Sandu Group of Companies, which was established in the year in 1899. It is also developing bio-technology and has got encouraging results for the residual, waste products generated after extraction of green herbs, roots, etc.

The company’s state-of-the-art manufacturing unit is located at Plot No. 25, 26, 29 and 30, Pilerne Industrial Estate, Marra, Bardez, Goa 403511.

Sandu Pharmaceuticals has received ISO 9001-2000 certification for its quality management.

It has also commenced operations of its ‘Sandu Ayurvedic Therapy Centre’, which its plans to establish centres across India via franchisee business model.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+0.54%
1 Week
-1.86%
1 Month
+0.27%
3 Month
+19.23%
6 Month
+71.30%
1 Year
+200.0%
2 Year
+317.29%
5 Year
+68.18%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 2.90 4.50 2.76 2.28 2.92 -2.44 3.09 3.53 3.66
Return on Capital Employed (%) 8.23 7.66 6.93 6.80 7.65 5.30 7.06 7.58 5.79
Return on Assets (%) 2.03 2.65 1.41 1.06 1.30 -1.01 1.23 1.52 1.69

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 17 18 18 18 19 27 28 29 29
Non Curr. Liab. 1 2 3 2 2 1 1 1 1
Curr. Liab. 7 14 16 21 21 18 15 14 11
Minority Int.
Equity & Liab. 26 33 37 42 41 46 45 44 41
Non Curr. Assets 7 9 10 9 9 18 24 24 19
Curr. Assets 18 24 27 32 33 28 21 20 22
Misc. Exp. not W/O
Total Assets 26 33 37 42 41 46 45 44 41

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 31 30 36 40 41 43 49 49 48
Other Income 0 0 0 0 0 0 0 1 0
Total Income 31 31 36 40 41 43 49 50 49
Total Expenditure -29 -28 -34 -37 -38 -41 -47 -47 -47
PBIDT 2 2 2 3 3 2 3 3 2
Interest -1 -1 -1 -1 -2 -1 -1 -1 0
Depreciation 0 0 -1 -1 -1 -1 -1 -1 -1
Taxation -1 0 0 0 0 -1 0 0 0
Exceptional Items 0
PAT 0 1 1 0 1 0 1 1 1

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 0 5 -1 5 -1 5 1 4 6
Cash Fr. Inv. -1 -2 -1 0 0 -1 -1 0 0
Cash Fr. Finan. 0 0 0 -2 -2 -2 -2 -4 -5
Net Change 0 3 -2 3 -3 2 -1 -1 1
Cash & Cash Eqvt 1 3 1 4 1 3 1 1 2

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 44.99 44.99 44.99 44.99 45.04 45.04 45.04 45.04 45.04
Public 55.01 55.01 55.01 55.01 54.96 54.96 54.96 54.96 54.96
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Thu, 22 Jul 2021
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements )Regulation 2015 for Stop Transfer.-SHILA DILIPKUMAR GOLECHHA
Wed, 21 Jul 2021
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements )Regulation 2015 for Stop Transfer of Mr Anil Shah
Mon, 19 Jul 2021
Shareholding for the Period Ended June 30 2021
Sandu Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here

Technical Scans View Details

Thu, 29 Jul 2021
Strongly Outperforming Benchmark Index Strongly Outperforming Benchmark Index
Strongly Outperforming Sectoral Index Strongly Outperforming Sectoral Index
Close Within 2 Year High Zone Close Within 2 Year High Zone
Close Within 5 Year High Zone Close Within 5 Year High Zone
Both SRS And ARS Above Zero Both SRS And ARS Above Zero

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 168,733.23 709.00 +0.8%
Divi's Laboratories Ltd. 128,656.69 4,880.10 +0.7%
Dr. Reddy's Laboratories Ltd. 77,707.65 4,736.50 +1.4%
Cipla Ltd. 71,170.06 882.35 +0.0%
Cadila Healthcare Ltd. 58,547.84 578.35 +1.1%
Apollo Hospitals Enterprise Ltd. 58,067.43 4,075.00 +0.9%
Aurobindo Pharma Ltd. 53,214.94 910.30 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 58.11 709.00 +0.8%
Divi's Laboratories Ltd. Consolidated 2021-03 64.84 4,880.10 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 44.73 4,736.50 +1.4%
Cipla Ltd. Consolidated 2021-03 29.59 882.35 +0.0%
Cadila Healthcare Ltd. Consolidated 2021-03 27.44 578.35 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 386.19 4,075.00 +0.9%
Aurobindo Pharma Ltd. Consolidated 2021-03 9.98 910.30 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 3.63 709.00 +0.8%
Divi's Laboratories Ltd. Consolidated 2021-03 13.84 4,880.10 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.35 4,736.50 +1.4%
Cipla Ltd. Consolidated 2021-03 3.88 882.35 +0.0%
Cadila Healthcare Ltd. Consolidated 2021-03 4.51 578.35 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.64 4,075.00 +0.9%
Aurobindo Pharma Ltd. Consolidated 2021-03 2.43 910.30 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 709.00 +0.8%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,880.10 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,736.50 +1.4%
Cipla Ltd. Consolidated 2020-03 0.18 882.35 +0.0%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 578.35 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,075.00 +0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 0.33 910.30 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 709.00 +0.8%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,880.10 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,736.50 +1.4%
Cipla Ltd. Consolidated 2020-03 10.09 882.35 +0.0%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 578.35 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,075.00 +0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.53 910.30 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 709.00 +0.8%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,880.10 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,736.50 +1.4%
Cipla Ltd. Consolidated 2020-03 12.53 882.35 +0.0%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 578.35 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,075.00 +0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.80 910.30 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 709.00 +0.8%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,880.10 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,736.50 +1.4%
Cipla Ltd. Consolidated 2020-03 17,131.99 882.35 +0.0%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 578.35 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,075.00 +0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 23,098.51 910.30 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 709.00 +0.8%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,880.10 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,736.50 +1.4%
Cipla Ltd. Consolidated 2020-03 1,546.98 882.35 +0.0%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 578.35 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,075.00 +0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 2,844.69 910.30 +0.2%